(Q35024511)

5 August 2017

1 reference

title

Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy (English)

1 reference

5 August 2017

Laurie K McCauley

1

1 reference

5 August 2017

Rahime M Nohutcu

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of Periodontology

5 August 2017

published in

1 reference

5 August 2017

volume

73

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1377-1391

1 reference

Dissociation between bone resorption and bone formation in osteopenic transgenic mice

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Vascular pericytes express osteogenic potential in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The osteoblast: a sophisticated fibroblast under central surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Periodontal tissue engineering by growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Molecular control of bone remodeling and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

A novel member of the leukocyte receptor complex regulates osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Interleukin 1 signal transduction--current concepts and relevance to periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

RANK-L and RANK: T cells, bone loss, and mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Bone markers in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Periodontal probing: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The use of periodontal probes and radiographs in clinical trials of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

A longitudinal study of various crevicular fluid components as markers of periodontal disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Evaluation of components of gingival crevicular fluid as diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Some Characteristics of Collagenase Activity in Gingival Crevicular Fluid and Its Relationship to Gingival Diseases in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Structural characterization of human alveolar bone proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The effects of orthodontic tooth movement on the glycosaminoglycan components of gingival crevicular fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Glycosaminoglycans in peri-implant sulcus fluid from implants supporting fixed or removable prostheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Cox-2-specific inhibitors: definition of a new therapeutic concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Alendronate treatment of naturally-occurring periodontitis in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Cytokines, bone remodeling, and estrogen deficiency: a 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Gingival fluid IL-1beta in postmenopausal females on supportive periodontal therapy. A longitudinal 2-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Osteoclasts, integrins, and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Effects of a bisphosphonate on experimental periodontitis in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

Effects of Tetracyclines on Bone Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.11.1377

10.1902/JOP.2002.73.11.1377

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference